Savara

NASDAQ SVRA
$4.48 0.0000 0.0000%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 17 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

817.82M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

817.73M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

1.11
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

182.55M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

-4.68 %

Upcoming events Savara

All events
No upcoming events scheduled

Stock chart Savara

Stock analysis Savara

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

-12.68 28.84
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

5.83 4.35
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

-11.66 10.00
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

- 0.65
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

-52.92 7.67

Price change Savara per year

1.00$ 2.49$
Min Max

Summary analysis Savara

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Savara

Revenue and net income Savara

All parameters

About company Savara

Savara Inc. operates as an orphan lung disease company. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.
Address:
Building III, Austin, TX, United States, 78746
Company name: Savara
Issuer ticker: SVRA
ISIN: US8051111016
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2017-06-01
Sector: Healthcare
Industry: Biotechnology
Site: https://www.savarapharma.com

On which stock exchange are Savara (SVRA) stocks traded?

Savara (SVRA) stocks are traded on NASDAQ.

What is the ticker of Savara stocks (SVRA)?

The stock ticker of Savara’s stocks or in other words, the code is SVRA. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Savara (SVRA) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Savara (SVRA) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Savara (SVRA) stocks traded?

Savara (SVRA) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Savara (SVRA) stocks today?

The current price of Savara stocks on 20.05.2024 is 4.48 dollars. per share.

What is the dynamics of Savara (SVRA) stocks from the beginning of the year?

Savara (SVRA) quotes have increased by 2.52% from the beginning of the year up to 4.48 dollars. per 1 stocks.

How much did Savara (SVRA) stocks increase in мае 2024?

This month Savara (SVRA) quotes have increased by -9.49% to 4.48 dollars. per share.

How much are Savara (SVRA) stocks worth?

Today, on October, 20.05.2024 Savara’s (SVRA) stocks cost 4.48 dollars..

What is the market capitalization of Savara (SVRA)?

Capitalization is the market value of Savara (SVRA) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 20.05.2024, the market capitalization of Savara (SVRA) is estimated at about 817824488 dollars.